跳至主要内容
临床试验/ACTRN12622000843752
ACTRN12622000843752尚未招募未知

Feasible, safety and utility of Endoscopic ultrasound-guided PPG measurement (EUS-PPGM) in patients undergoing liver resection and major intra-abdominal surgeries.

Waikato District Health Board - Waikato Hospital0 个研究点目标入组 40 人开始时间: 2022年6月15日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 o limit(—)
性别
All

入选标准

  • · Patients with cancer in the liver (with or without cirrhosis) who are recommended for liver resection or liver transplant
  • · Patients with cirrhosis who are recommended to undergo abdominal surgery

排除标准

  • Exclusion criteria
  • · International Normalised Ratio (INR) > 1.6 (as part of the standard of care)
  • · Significant ascites
  • · Child-Pugh C severity of cirrhosis
  • · Presence of large gastric varices or periportal collateral vessels that prevent EUS approach to the hepatic and/or portal vasculature

研究者

发起方
Waikato District Health Board - Waikato Hospital

相似试验

Feasible, safety and utility of Endoscopic... | 临床试验